UNSPSC 51392215: Tolonidine

This classification denotes an alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I4O795Q03O. European Medicines Agency schedules Tolonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11167MIG. Tolonidine generally arises in the molecular formula C10H12CLN3. The term TOLONIDINE is an International Non-Proprietary Name or INN. TOLONIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule tolonidine under HS 29332990 and SITC 51573. As of Q4 2014, TOLONIDINE remains the US FDA Preferred Term for this commodity. Tolonidine bears US NLM identifiers UMLS ID C0076803 and NCI Concept Code C75048. SMILES: CC1=CC(=C(C=C1)NC2=NCCN2)CL.

UNSPSC 51392215 Tolonidine (Commodity) describes pharmaceutical products, but the recent state and local opportunity posted under this code shows a significant mismatch between the code's nominal scope and actual procurement activity. Seminole County, Florida issued IFB60459723LAS in June 2026 to procure naloxone and safe drug deactivation systems — neither of which is tolonidine — for community health initiatives with quarterly deliveries to the Seminole County Community Health Building. The code shows minimal recent activity aligned to its stated pharmaceutical scope and does not reflect a meaningful procurement category for state and local vendors pursuing this work under its assigned taxonomy.

The single recent opportunity under this code originates from a county health department, but the misalignment between the code designation and the actual goods being solicited suggests the code does not represent a reliable or actively used classification for state and local procurement in this product family. Seminole County's IFB required electronic bid submission through its e-Procurement Portal with a response deadline of July 26, 2023, inclusive of delivery costs, two-year initial term with one-year renewal option, and standard compliance certifications including E-Verify and drug-free workplace requirements. Vendors should verify the correct UNSPSC code for naloxone and drug deactivation system procurement rather than rely on the tolonidine designation.